Short-term outcomes in patients with acute coronary syndrome treated with direct bioresorbable scaffold deployment
详细信息 查看全文
- 作者：Ayyaz Sultan ; Varinder Randhawa ; Anthony C. Camuglia ; Shahar Lavi ; shahar.lavi@lhsc.on.ca" class="auth_mail" title="E-mail the corresponding author
- 关键词：Bioresorbable vascular scaffold ; Direct coronary stenting ; Myocardial infarction
- 刊名：Cardiovascular Revascularization Medicine
- 出版年：2015
- 出版时间：October-November 2015
- 年：2015
- 卷：16
- 期：7
- 页码：381-385
- 全文大小：833 K
文摘
- •
Limited evidence for use of bioresorbable vascular scaffold (BVS) in ACS patients.
- •
Eight patients had acute STEMI and underwent primary PCI with BVS.
- •
No cases of worsening flow, scaffold thrombosis, TLR or death to 30 days post PCI.
- •
Direct BVS deployment in ACS appears safe and feasible.